The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

Chathuri Yatawara1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Fatin Zahra Zailan1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Esther Vanessa Chua1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Linda Lay Hoon Lim1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Eveline Silva1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Joanna Sihan Wang1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Adeline Ng1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Kok Pin Ng1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore

Nagaendran Kandiah1 Department of Neurology, National Neuroscience Institute, Singapore, Singapore;2 Duke-NUS Medical School, Singapore, Singapore;3 Lee Kong Chian School of Medicine-Imperial College London, Nanyang Technological University, Singapore, SingaporeCorrespondence[email protected]

show all

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date